🧔♂️ A friendly human may check it before it goes live. More news here
OpenAI unveils benchmark to test AI on medicinal chemistry
OpenAI on November 20 introduced MedChemBench, a benchmark with 99 medicinal chemistry problems that test molecular reconstruction, evidence interpretation, compound selection, and property prediction.
The company said GPT-6.2 Astra earned 84.5% of available credit at xhigh reasoning effort, compared with 83.3% for GPT-6 Astra. The benchmark draws on 117 papers and patents.
OpenAI cautioned that the results do not establish drug discovery ability or better laboratory decisions. Prior exposure to the source material cannot be ruled out, and each response was a single attempt without tools, feedback, or new experiments.
Medicinal chemistry helps refine lead compounds to improve potency, selectivity, absorption, distribution, metabolism, and excretion, and safety before researchers select a clinical candidate.
The announcement referenced a preprint but did not confirm whether OpenAI would release the dataset or code.
Materials from the US Food and Drug Administration described AI being considered across drug development and said models generating evidence for regulatory submissions should be validated and fit for purpose.
🔗 Source: OpenAI




